Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 31 - What They Never Told You

USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms

USA Rare Earth continues to make progress on its mine-to-magnet rare-earth ambitions, posting solid financials as it waits for a massive acquisition to close.

MarketBeat

3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO

As SpaceX eyes a potential June IPO, capital is flowing into space infrastructure stocks like LUNR, RDW, and VOYG, each posting record backlogs in Q1 2026.

MarketBeat

Mirum Pharma: A Rare Disease Growth Story to Watch

Mirum stock pulled back after earnings despite strong growth. Here’s why investors still see upside in the rare disease biotech company

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

The Great AI Rotation: Cashing In on Data

As AI data demands surge, memory fabricators are capitalizing on a structural supply shortage, leading to a historic pricing supercycle.

MarketBeat

V.F. Q4 Earnings Call Highlights

V.F. (NYSE:VFC) executives said the apparel and footwear company ended fiscal 2026 with improving sales trends, wider margins and lower leverage, while reinstating annual guidance for fiscal 2027. President and CEO Bracken Darrell said the company “finished this year strong” and exceeded its fourth

MarketBeat

Arcos Dorados Q1 Earnings Call Highlights

Arcos Dorados (NYSE:ARCO) reported a stronger first quarter of 2026, with management saying revenue, adjusted EBITDA and cash flow improved despite a challenging consumer environment in parts of Latin America. Chief Executive Officer Luis Raganato said total revenue rose about 13% and exceeded $1.2

MarketBeat

Ellington Credit Q1 Earnings Call Highlights

Ellington Credit (NYSE:EARN) reported a GAAP net loss of $0.86 per share for the quarter ended March 31, 2026, as volatility in the collateralized loan obligation market weighed on asset valuations, particularly CLO equity holdings. Chief Executive Officer Larry Penn said the first calendar quarter

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

The Great Cloud Divide: How AI Is Reshuffling the Software Deck

ServiceNow and Salesforce are charting divergent paths in the AI revolution, with one building core infrastructure and the other leveraging its massive scale.

MarketBeat

Eagle Materials: A Dividend-Paying Brick & Mortar AI Play

Eagle Materials is in position to reverse course after solid FQ4 results highlight industrial cement demand, demand linked to datacenters and AI.

MarketBeat

Analog Devices Provides Much-Needed Pullback: How Low Can It Go?

Analog Devices is well-positioned for an AI-driven supercycle that will extend to all parts of the tech world and create positive feedback loops for business.

MarketBeat

Candel Therapeutics Eyes Year-End BLA After Strong Prostate Cancer Data

Candel Therapeutics (NASDAQ:CADL) Chief Executive Officer Dr. Paul Peter Tak said the company remains focused on advancing its viral immunotherapy programs following newly presented prostate cancer data and as it prepares for a planned biologics license application submission by the end of the year.

MarketBeat

Toll Brothers Q2 Earnings Call Highlights

Toll Brothers (NYSE:TOL) executives said the luxury homebuilder delivered better-than-expected fiscal second-quarter results despite a challenging demand environment, prompting the company to raise its full-year guidance across key homebuilding metrics. Executive Chairman Doug Yearley said the comp

MarketBeat

Dorian LPG Q4 Earnings Call Highlights

Dorian LPG (NYSE:LPG) executives said the company benefited from a stronger VLGC freight market in its fiscal fourth quarter, while emphasizing a cautious capital allocation approach as the sector faces volatile geopolitics, high Panama Canal costs and an expanding orderbook. On the company’s fourt

MarketBeat

Target Q1 Earnings Call Highlights

Target (NYSE:TGT) reported stronger-than-expected first-quarter results for fiscal 2026, with executives saying early merchandising and operational changes are beginning to resonate with shoppers, while cautioning that the company remains in the early stages of a broader turnaround effort. Chief Ex

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Lowe's Companies Q1 Earnings Call Highlights

Lowe's Companies (NYSE:LOW) reported a modest comparable sales gain in its fiscal first quarter, with executives pointing to stronger spring execution, continued demand from professional customers and growth in online and home services as offsets to a still-pressured do-it-yourself market. The home

MarketBeat

Analog Devices Q2 Earnings Call Highlights

Analog Devices (NASDAQ:ADI) reported record fiscal second-quarter 2026 results, with revenue, profitability and earnings per share exceeding the high end of the company’s prior guidance, executives said on the company’s earnings call. Chief Executive Officer and Chair Vincent Roche said the quarter

MarketBeat

Auna Q1 Earnings Call Highlights

Auna (NYSE:AUNA) reported stronger first-quarter revenue and cash flow across its regional healthcare platform, while adjusted EBITDA declined as the company absorbed revenue adjustments in Peru and higher payroll costs in Mexico and Colombia. Executive Chairman and President Jesús Zamora said the

MarketBeat

Arhaus Stock Drops to 52-Week Low After Q1 Earnings

Arhaus stock continues to slide after weak first-quarter comparable sales and cautious near-term guidance overshadows better-than-expected revenue.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Tesla Ends Model S and X Era, Bets Everything on What's Next

Tesla's pivot from EVs to robotics and autonomy is gaining momentum, but with analysts cooling and its multiple stretched, long-term belief is required.

MarketBeat

Perion Network Q1 Earnings Call Highlights

Perion Network (NASDAQ:PERI) reported modest first-quarter revenue growth while management highlighted rising adoption of its Perion One platform and Outmax AI agent as the company continues to shift away from legacy web and search economics toward channel-agnostic advertising infrastructure. On th

MarketBeat

Roivant Sciences Q4 Earnings Call Highlights

Roivant Sciences (NASDAQ:ROIV) executives used the company’s fourth-quarter earnings call to highlight new open-label data for IMVT-1402 in difficult-to-treat rheumatoid arthritis, upcoming pulmonary hypertension data for mosliciguat and continued preparation for a potential brepocitinib launch in d

MarketBeat

Arrowhead Pharmaceuticals Eyes Q3 SHASTA Data as REDEMPLO Approvals Build Momentum

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives said the company is entering a key period marked by new regulatory approvals, early commercial progress for REDEMPLO and upcoming Phase 3 data in severe hypertriglyceridemia, during a fireside chat at RBC Capital Markets’ 2026 Global Healthcare Conf

MarketBeat

TAT Technologies Q1 Earnings Call Highlights

TAT Technologies (NASDAQ:TATT) said first-quarter 2026 revenue slipped slightly from a year earlier as supply chain disruptions delayed the completion and delivery of some aerospace maintenance work, but management said demand remains at record levels and reaffirmed its expectation for meaningful fu

MarketBeat

Immunovant Q4 Earnings Call Highlights

Roivant executives used the company’s fourth-quarter and fiscal-year earnings call to highlight new clinical data from its development portfolio, upcoming readouts and its strengthened balance sheet following a settlement with Moderna. Matthew Klein, CEO of Roivant, said the company has had “a pret

MarketBeat

EuroDry Q1 Earnings Call Highlights

EuroDry (NASDAQ:EDRY) reported a return to profitability in the first quarter of 2026, supported by stronger charter rates despite operating a smaller average fleet than a year earlier, while management said it is expanding its newbuilding program with two additional Kamsarmax bulk carriers. Chairm

1 … 30 31 32 33

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.